• About Us
  • Contact
FNN
  • News Categories
    • Company News
    • Interviews
    • Market Reports
    • Stock Watch
    • Company Presentations
    • Funds Management
  • Funds Management
    • Acorn Capital
      • Acorn Capital Investment Fund
    • Altrinsic
      • Altrinsic Global Advisors
    • Antares
      • Antares Australian Equities Fund
      • Antares Dividend Builder
      • Antares Elite Opportunities Fund
      • Antares Fixed Income Fund
      • Antares Listed Property Fund
    • Ausbil
      • Ausbil 130/30 Focus Fund
      • Ausbil Active Sustainable Equity Fund
      • Ausbil Australian Active Equity Fund
      • Ausbil Australian Emerging Leaders Fund
      • Ausbil MicroCap Fund
    • Capital Property Funds
      • Capital Property Funds
    • Fairview
      • Fairview Equity Partners Emerging Companies
    • Hunter Hall
      • Hunter Hall Global Value
    • Intermede
      • Intermede Global Equities Fund
    • MLC
      • MLC Inflation Plus
    • Presima
      • Presima Global Property Securities Concentrated Fund
    • ResiFund
      • ResiFund
    • Ruffer
      • Ruffer
    • Russell Investments
      • Russell Investments
    • Tribeca Investment Partners
      • Tribeca Investment Partners
    • VanEck
      • VanEck
  • Expert Insights
    • Jeffrey Liu
    • Michael Gable
    • Patrick Taylor
  • Media Releases
  • Investor Events
    • FNN Events

Media Releases › Immutep

View All Immutep News


Immutep - Webcast slides for AIPAC Phase IIb breast cancer trial

11 Dec 2020 08:26 AM


To view the presentation, download the attached PDF.

 Download this document

Subscribe

Subscribe for our daily email digest

Company Directors

  • Mr Tom Bloomfield (Company Secretary)
  • Mr Grant Chamberlain (Non Exec. Director)
  • Dr Russell John Howard (Non Exec. Director, Chairman)
  • Mr Pete Meyers (Non Exec. Director, Deputy Chairman)
  • Ms Deanne Miller (General Counsel, Company Secretary, Chief Op. Officer)
  • Mr Marc Voigt (CEO, Executive Director)

Contact Information

  • +61 2 8315 7003
  • enquiries@immutep.com
  • http://www.immutep.com
  • Lvl 12, 95 Pitt St, Sydney, NSW, Australia, 2000

Latest Company News

BINGO (ASX:BIN) has recieved a $3.50 a share cash bid

8 hours ago

HUB24 (ASX:HUB) grew Funds Under Admnistration to $22 billion in December quarter

8 hours ago

Rio Tinto (ASX:RIO) report iron ore shipments up 2% on last year

8 hours ago

Mineral Commodities Ltd (ASX:MRC) secures additional graphite prospects

8 hours ago

JB Hi-Fi (ASX:JBH) profit jumps 86 per cent

Yesterday

Super Retail (ASX:SUL) sales soar 23 per cent

Yesterday

Latest Media Releases

Altech Chemicals - Response to ASX Price and Volume Query

Yesterday

MMJ Group Holdings - Management Agreement with Embark Ventures Inc Update

Yesterday

Cyclopharm - USFDA Approval Progress for Technegas and Business Update

5 days ago

MMJ Group Holdings Investment Portfolio Report December 2020

5 days ago

Noxopharm Announces NOXCOVID Study Advances

6 days ago

Spacetalk - Business Update

11 days ago

Immutep - Recruitment of head & neck cancer patients completed for ph2

12 days ago

Lepidico - Top 20 Shareholders

12 days ago

Noxopharm Shareholder Update 2021

13 days ago

Spacetalk to showcase at CES

14 days ago

Recent Insights

Growth Focus: Neometals Ltd (NMT)

17/12/2020 15:04

Post-Covid Wealth Management Strategy

17/12/2020 12:07

Jeffrey Liu

16/12/2020 12:40

Growth Focus: SRG Global Ltd (SRG)

05/12/2020 15:42

Growth Focus: New Century Zinc Ltd (NCZ)

09/11/2020 15:41

FNN

ABN 31 117 966 328
Disclaimer
Privacy Policy

Categories

  • Company News
  • Market Reports
  • Interviews
  • Presentations
  • Funds Management

Newsletter

Receive Daily News to your email

Recent Companies

  • ASX:AFP
  • ASX:AIS
  • ASX:APT
  • Nasdaq:AFRM
  • ASX:FPH
  • ASX:PYR
  • ASX:PME
  • ASX:CUV
  • ASX:RSG
  • ASX:PNV
  • ASX:Z1P
  • ASX:AST
  • ASX:FAR
  • ASX:TGA
  • ASX:CPH
  • ASX:MX1
  • ASX:CAN
  • ASX:WCG
  • ASX:ASX
  • ASX:CWY
  • ASX:BIN
  • ASX:CHC
  • ASX:NHF
  • ASX:ATH
  • ASX:AX1
  • ASX:BDA
  • ASX:BIN
  • ASX:BSX
  • ASX:CAN
  • ASX:CDV
  • ASX:CGC
  • ASX:STX
  • ASX:COF
  • ASX:BLD
  • ASX:CPH
  • ASX:CYC
  • ASX:PLS
  • ASX:WHC
  • ASX:PLL
  • ASX:DMP
  • ASX:NVX
  • ASX:FCL
  • ASX:OBL
  • ASX:MYX
  • ASX:TYR
  • ASX:TRN
  • ASX:GLL
  • ASX:NCM
  • ASX:NOX
  • ASX:GMD

Copyright Finance TV Pty Ltd All Rights Reserved

  • Home
  • News Categories
    • Company News
    • Interviews
    • Market Reports
    • Stock Watch
    • Company Presentations
    • Funds Management
  • Funds Management
    • Acorn Capital
      • Acorn Capital Investment Fund
    • Altrinsic
      • Altrinsic Global Advisors
    • Antares
      • Antares Australian Equities Fund
      • Antares Dividend Builder
      • Antares Elite Opportunities Fund
      • Antares Fixed Income Fund
      • Antares Listed Property Fund
    • Ausbil
      • Ausbil 130/30 Focus Fund
      • Ausbil Active Sustainable Equity Fund
      • Ausbil Australian Active Equity Fund
      • Ausbil Australian Emerging Leaders Fund
      • Ausbil MicroCap Fund
    • Capital Property Funds
      • Capital Property Funds
    • Fairview
      • Fairview Equity Partners Emerging Companies
    • Hunter Hall
      • Hunter Hall Global Value
    • Intermede
      • Intermede Global Equities Fund
    • MLC
      • MLC Inflation Plus
    • Presima
      • Presima Global Property Securities Concentrated Fund
    • ResiFund
    • Ruffer
    • Russell Investments
    • Tribeca Investment Partners
    • VanEck
  • Expert Insights
    • Jeffrey Liu
    • Michael Gable
    • Patrick Taylor
  • Media Releases
  • Investor Events
    • FNN Events